National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

valganciclovir
A synthetic prodrug of ganciclovir, a nucleoside analogue of 2'-deoxyguanosine, with antiviral activity. After phosphorylation, valganciclovir is incorporated into DNA, resulting in inhibition of viral DNA polymerase, viral DNA synthesis, and viral replication. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Valcyte
Abbreviation:VGCV



Previous:Vagestrol, valacyclovir, Valcyte, valdecoxib, Valeriana officinalis extract
Next:valproic acid, valrubicin, valsartan, valspodar, Valstar

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov